前鼻孔
殖民地化
金黄色葡萄球菌
微生物学
万古霉素
医学
生物
耐甲氧西林金黄色葡萄球菌
细菌
遗传学
作者
Ramana, KV,R. Srinivasa Rao
摘要
Staphylococcus aureus infections form a major part of hospital acquired infections. Although 20-40% of healthy individuals carry S. aureus in the anterior nares, it continues to be a major cause of both hospital and community acquired infections around the world. S. aureus, not only has a unique epidemiological pattern, but also can develop resistance to antibiotics. Because of its exceptional ability to colonise patients and healthy individuals, it is responsible for wide spread epidemics. In late 1930’s, when Sulphonamides offered the first challenge to S. aureus infections and later in the early 1940’s by Penicillins, over a period of time, S. aureus is constantly emerging resistant to a wide variety of antibiotics such as Semisynthetic Penicillins,aminoglycosides, macroloides,quinolones, glycopeptides and many other class of antibiotics. For more than three decades, vancomycin has been a reliable treatment for multidrug resistant S. aureus infections. But with the discovery of S. aureus strains with reduced susceptibility to Vancomycin in 1996 in Europe, Asia and US, hinders our efforts to clarify the effectiveness of Vancomycin in the treatment of Staphylococcal infections. Of late there have been increasing reports of Vancomycin intermediate (VISA) and Vancomycin resistant (VRSA) Staphylococal strains both in hospital and community.
科研通智能强力驱动
Strongly Powered by AbleSci AI